CLINICAL EFFICACY OF PROBIOTIC LACTIV-RATIOFARM IN RELIEF OF INTESTINAL DYSPEPSIA SYMPTOMS


Citar

Texto integral

Resumo

The present article is concerned with the questions of pathogenesis and treatment of intestinal dyspepsia. The results of the use of probiotic Lactiv-ratiofarm in 40 patients with symptoms of intestinal dyspepsia and suffering from diseases of the digestive system are presented. After 2-week course of the use of Lactiv-ratiofarm, positive therapeutic effect was observed in all 40 patients enrolled in the study (discomfort in the abdomen, borborygmus and bloating, and abdominal wall pain tenderness were significantly decreased or disappeared). The use of Lactiv-ratiofarm was not accompanied by the development of any adverse events. As a result, all 40 patients have expressed satisfaction with the therapy.

Bibliografia

  1. Гребенев А.Л., Мягкова Л.П. Болезни кишечника (современные достижения в диагностике и терапии). М., 1994. С. 400.
  2. Микрофлора пищеварительного тракта / Под ред. А.И. Хавкина. М.: Фонд социальной педиатрии. 2006. С. 416.
  3. Парфенов А.И., Бондаренко В.М. Регуляция соотношения между нормальной и патологической микрофлорой кишечника // Гастроэнтерология. Приложение Consilium medicum. 2009. № 2. С. 67-70.
  4. Щекина М.И. Роль пробиотиков в коррекции дисбиотических нарушений // Гастроэнтерология. Приложение Consilium medicum. 2009. № 2. С. 36-42.
  5. Floch MH, Stone K, Jung LK. Recommendations for probiotic use. J Clin Gastroenterol 2008;42(2):104-8.
  6. Quigley EM. Probiotics. The key to digestive health. Health Point Press 2009;44.
  7. Ringel Y, Patersign Z. Prevalence, characteristics and impact of bloating symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2009;7(1):68-72.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2010